Goldman Sachs Group Inc. Reduces Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Goldman Sachs Group Inc. lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 51.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 578,707 shares of the company’s stock after selling 605,293 shares during the period. Goldman Sachs Group Inc. owned 0.33% of Option Care Health worth $19,497,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Teachers Retirement System of The State of Kentucky lifted its position in shares of Option Care Health by 40.9% during the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 394,254 shares of the company’s stock worth $13,282,000 after acquiring an additional 114,509 shares in the last quarter. P2 Capital Partners LLC purchased a new stake in shares of Option Care Health during the fourth quarter worth $13,019,000. Gilder Gagnon Howe & Co. LLC lifted its position in shares of Option Care Health by 0.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 1,281,299 shares of the company’s stock worth $43,167,000 after acquiring an additional 4,885 shares in the last quarter. Putnam Investments LLC lifted its position in shares of Option Care Health by 8.0% during the fourth quarter. Putnam Investments LLC now owns 1,802,380 shares of the company’s stock worth $60,722,000 after acquiring an additional 134,187 shares in the last quarter. Finally, Ranger Investment Management L.P. increased its holdings in shares of Option Care Health by 112.4% in the fourth quarter. Ranger Investment Management L.P. now owns 888,495 shares of the company’s stock worth $29,933,000 after purchasing an additional 470,132 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 24th. Jefferies Financial Group upped their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Option Care Health Stock Down 0.1 %

OPCH opened at $28.12 on Thursday. The stock has a market cap of $4.89 billion, a PE ratio of 18.50, a P/E/G ratio of 1.37 and a beta of 1.31. The company has a quick ratio of 1.39, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. Option Care Health, Inc. has a 52 week low of $26.17 and a 52 week high of $35.74. The business’s fifty day simple moving average is $29.43 and its 200 day simple moving average is $31.33.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The business had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The firm’s revenue was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.21 earnings per share. As a group, research analysts expect that Option Care Health, Inc. will post 1.19 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.